MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Williams, K.
Right arrow Articles by Molinoff, P. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Williams, K.
Right arrow Articles by Molinoff, P. B.

Sensitivity of the N-methyl-D-aspartate receptor to polyamines is controlled by NR2 subunits

K Williams, AM Zappia, DB Pritchett, YM Shen and PB Molinoff

Department of Pharmacology, University of Pennsylvania School of Medicine, Philadelphia 19104-6084.

The endogenous polyamine spermine has multiple effects on the N-methyl- D-aspartate (NMDA) receptor. These include an increase in the magnitude of NMDA-induced whole-cell currents that is seen in the presence of saturating concentrations of glycine ("glycine-independent" stimulation), an increase in the affinity of the receptor for glycine ("glycine-dependent" stimulation), and voltage-dependent inhibition. Although many of the properties of native NMDA receptors are seen with homomeric NR1 receptors expressed in Xenopus oocytes, we have found that the effects of spermine are differentially regulated by NR2 subunits in heteromeric NR1/NR2 receptors. Glycine-independent stimulation by spermine occurred at homomeric NR1A receptors, which lack the amino-terminal insert in NR1, and at heteromeric NR1A/NR2B receptors but not at heteromeric NR1A/NR2A or NR1A/NR2C receptors. Glycine-independent stimulation was not seen at homomeric NR1B receptors, which include the amino-terminal insert in NR1, or at heteromeric receptors containing NR1B. Thus, glycine-independent stimulation by polyamines requires the presence of an NR1 variant, such as NR1A, that lacks the amino-terminal insert, but the manifestation of the stimulatory effect is controlled by the type of NR2 subunit present in a heteromeric complex. Glycine-dependent stimulation was seen at NR1A/NR2A and NR1A/NR2B receptors and may therefore involve a second polyamine binding site distinct from that which produces glycine- independent stimulation. The voltage-dependent inhibitory effect of spermine, which is more pronounced at hyperpolarized membrane potentials, occurred with similar magnitudes at NR1A/NR2A and NR1A/NR2B receptors but was absent at NR1A/NR2C receptors. Thus, NR2 subunits control both the stimulatory and inhibitory effects of spermine at NMDA receptors. Stimulation but not inhibition by spermine was seen at NR1A/NR2B receptors in the presence of extracellular Mg2+. Stimulation, seen in the presence of physiological concentrations of Ca2+ and Mg2+, may be the predominant effect of polyamines at NMDA receptors in the intact nervous system.

Volume 45, Issue 5, pp. 803-809, 05/01/1994
Copyright © 1994 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Biophys. JHome page
L. Stoll, J. Hall, N. Van Buren, A. Hall, L. Knight, A. Morgan, S. Zuger, H. Van Deusen, and L. Gentile
Differential Regulation of Ionotropic Glutamate Receptors
Biophys. J., February 15, 2007; 92(4): 1343 - 1349.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
K. Erreger, S. M Dravid, T. G Banke, D. J. A Wyllie, and S. F Traynelis
Subunit-specific gating controls rat NR1/NR2A and NR1/NR2B NMDA channel kinetics and synaptic signalling profiles
J. Physiol., March 1, 2005; 563(2): 345 - 358.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
K. Kashiwagi, I. Tanaka, M. Tamura, H. Sugiyama, T. Okawara, M. Otsuka, T. N. Sabado, K. Williams, and K. Igarashi
Anthraquinone Polyamines: Novel Channel Blockers to Study N-Methyl-D-Aspartate Receptors
J. Pharmacol. Exp. Ther., June 1, 2004; 309(3): 884 - 893.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. W. Floyd, K.-Y. Jung, and B. A. McCool
Chronic Ethanol Ingestion Facilitates N-Methyl-D-aspartate Receptor Function and Expression in Rat Lateral/Basolateral Amygdala Neurons
J. Pharmacol. Exp. Ther., December 1, 2003; 307(3): 1020 - 1029.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. W. Dunah and D. G. Standaert
Dopamine D1 Receptor-Dependent Trafficking of Striatal NMDA Glutamate Receptors to the Postsynaptic Membrane
J. Neurosci., August 1, 2001; 21(15): 5546 - 5558.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
Th. Els, J. Bruckmann, G. Rohn, M. Daffertshofer, J. S. Monting, R.-I. Ernestus, and M. Hennerici
Spermidine: A Predictor for Neurological Outcome and Infarct Size in Focal Cerebral Ischemia?
Stroke, January 1, 2001; 32(1): 43 - 46.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
G. Rumbaugh, K. Prybylowski, J. F. Wang, and S. Vicini
Exon 5 and Spermine Regulate Deactivation of NMDA Receptor Subtypes
J Neurophysiol, March 1, 2000; 83(3): 1300 - 1306.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. W. Dunah, Y. Wang, R. P. Yasuda, K. Kameyama, R. L. Huganir, B. B. Wolfe, and D. G. Standaert
Alterations in Subunit Expression, Composition, and Phosphorylation of Striatal N-Methyl-D-Aspartate Glutamate Receptors in a Rat 6-Hydroxydopamine Model of Parkinson's Disease
Mol. Pharmacol., February 1, 2000; 57(2): 342 - 352.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
G. Rumbaugh and S. Vicini
Distinct Synaptic and Extrasynaptic NMDA Receptors in Developing Cerebellar Granule Neurons
J. Neurosci., December 15, 1999; 19(24): 10603 - 10610.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
G. Martin, S. H. Ahmed, T. Blank, J. Spiess, G. F. Koob, and G. R. Siggins
Chronic Morphine Treatment Alters NMDA Receptor-Mediated Synaptic Transmission in the Nucleus Accumbens
J. Neurosci., October 15, 1999; 19(20): 9081 - 9089.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. C. Harvey and P. Skolnick
Polyamine-Like Actions of Aminoglycosides at Recombinant N-Methyl-D-Aspartate Receptors
J. Pharmacol. Exp. Ther., October 1, 1999; 291(1): 285 - 291.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
T. Masuko, T. Kuno, K. Kashiwagi, T. Kusama, K. Williams, and K. Igarashi
Stimulatory and Inhibitory Properties of Aminoglycoside Antibiotics at N-Methyl-D-Aspartate Receptors
J. Pharmacol. Exp. Ther., September 1, 1999; 290(3): 1026 - 1033.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
T. Masuko, K. Kashiwagi, T. Kuno, N. D. Nguyen, A. J. Pahk, J.-i. Fukuchi, K. Igarashi, and K. Williams
A Regulatory Domain (R1-R2) in the Amino Terminus of the N-Methyl-D-Aspartate Receptor: Effects of Spermine, Protons, and Ifenprodil, and Structural Similarity to Bacterial Leucine/Isoleucine/Valine Binding Protein
Mol. Pharmacol., June 1, 1999; 55(6): 957 - 969.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
T. A. Sharma and I. J. Reynolds
Characterization of the Effects of Polyamines on [125I]MK-801 Binding to Recombinant N-Methyl-D-Aspartate Receptors
J. Pharmacol. Exp. Ther., May 1, 1999; 289(2): 1041 - 1047.
[Abstract] [Full Text]


Home page
Cereb CortexHome page
F. Conti, P. Barbaresi, M. Melone, and A. Ducati
Neuronal and Glial Localization of NR1 and NR2A/B Subunits of the NMDA Receptor in the Human Cerebral Cortex
Cereb Cortex, March 1, 1999; 9(2): 110 - 120.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
R. Dingledine, K. Borges, D. Bowie, and S. F. Traynelis
The Glutamate Receptor Ion Channels
Pharmacol. Rev., March 1, 1999; 51(1): 7 - 62.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
W. Danysz and C. G. Parsons
Glycine and N-Methyl-D-Aspartate Receptors: Physiological Significance and Possible Therapeutic Applications
Pharmacol. Rev., December 1, 1998; 50(4): 597 - 664.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. F. Traynelis, M. F. Burgess, F. Zheng, P. Lyuboslavsky, and J. L. Powers
Control of Voltage-Independent Zinc Inhibition of NMDA Receptors by the NR1 Subunit
J. Neurosci., August 15, 1998; 18(16): 6163 - 6175.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. C. Brimecombe, M. J. Gallagher, D. R. Lynch, and E. Aizenman
An NR2B Point Mutation Affecting Haloperidol and CP101,606 Sensitivity of Single Recombinant N-Methyl-D-Aspartate Receptors
J. Pharmacol. Exp. Ther., August 1, 1998; 286(2): 627 - 634.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
G. Fischer, V. Mutel, G. Trube, P. Malherbe, J. N. C. Kew, E. Mohacsi, M. P. Heitz, and J. A. Kemp
Ro 25-6981, a Highly Potent and Selective Blocker of N-Methyl-D-aspartate Receptors Containing the NR2B Subunit. Characterization in Vitro
J. Pharmacol. Exp. Ther., December 1, 1997; 283(3): 1285 - 1292.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
M. Park-Chung, F.-S. Wu, R. H. Purdy, A. A. Malayev, T. T. Gibbs, and D. H. Farb
Distinct Sites for Inverse Modulation of N-Methyl-D-Aspartate Receptors by Sulfated Steroids
Mol. Pharmacol., December 1, 1997; 52(6): 1113 - 1123.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
M. J. Gallagher, H. Huang, E. R. Grant, and D. R. Lynch
The NR2B-specific Interactions of Polyamines and Protons with the N-Methyl-D-aspartate Receptor
J. Biol. Chem., October 3, 1997; 272(40): 24971 - 24979.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. C. Brimecombe, F. A. Boeckman, and E. Aizenman
Functional consequences of NR2 subunit composition in single recombinant N-methyl-D-aspartate receptors
PNAS, September 30, 1997; 94(20): 11019 - 11024.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
P. Paoletti, P. Ascher, and J. Neyton
High-Affinity Zinc Inhibition of NMDA NR1-NR2A Receptors
J. Neurosci., August 1, 1997; 17(15): 5711 - 5725.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. Chao, N. Seiler, J. Renault, K. Kashiwagi, T. Masuko, K. Igarashi, and K. Williams
N1-Dansyl-Spermine and N1-(n-Octanesulfonyl)-Spermine, Novel Glutamate Receptor Antagonists: Block and Permeation of N-Methyl-D-Aspartate Receptors
Mol. Pharmacol., May 1, 1997; 51(5): 861 - 871.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
L. L. Coughenour and J. J. Cordon
Characterization of Haloperidol and Trifluperidol as Subtype-Selective N-Methyl-D-Aspartate (NMDA) Receptor Antagonists Using [3H]TCP and [3H]Ifenprodil Binding in Rat Brain Membranes
J. Pharmacol. Exp. Ther., February 1, 1997; 280(2): 584 - 592.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
M. J. Gallagher, H. Huang, D. B. Pritchett, and D. R. Lynch
Interactions between Ifenprodil and the NR2B Subunit of the N-Methyl-D-aspartate Receptor
J. Biol. Chem., April 19, 1996; 271(16): 9603 - 9611.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1994 by the American Society for Pharmacology and Experimental Therapeutics